Michail Spanos
Overview
Explore the profile of Michail Spanos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Meng D, Shi X, Hou Y, Zang S, Chen L, et al.
Cell Rep Med
. 2025 Mar;
:101987.
PMID: 40037358
Cardiac ischemic reperfusion injury (IRI) significantly exacerbates cardiac dysfunction and heart failure, causing high mortality. Despite the severity of IRI, effective therapeutic strategies remain elusive. Acellular cardiac patches have shown...
2.
Zhang X, Ye X, Xie Y, Yang Z, Spanos M, Guo Z, et al.
Research (Wash D C)
. 2025 Feb;
8:0609.
PMID: 39949511
The prevention of air pollution-related cardiopulmonary disorders has been largely overlooked despite its important burden. Extracellular vesicles (EVs) have shown great potential as carriers for drug delivery. However, the efficiency...
3.
Cui X, Spanos M, Zhao C, Wan W, Cui C, Wang L, et al.
J Cardiovasc Transl Res
. 2025 Jan;
PMID: 39863753
HFpEF is a prevalent and complex type of heart failure. The concurrent presence of conditions such as obesity, hypertension, hyperglycemia, and hyperlipidemia significantly increase the risk of developing HFpEF. Mitochondria,...
4.
Pan L, Ai S, Shi X, Tong X, Spanos M, Li G, et al.
J Sport Health Sci
. 2025 Jan;
101027.
PMID: 39827990
Background: Exercise induces molecular changes that involve multiple organs and tissues. Moreover, these changes are modulated by various exercise parameters-such as intensity, frequency, mode, and duration-as well as by clinical...
5.
Spanos M, Gokulnath P, Li G, Hutchins E, Meechoovet B, Sheng Q, et al.
medRxiv
. 2024 Oct;
PMID: 39371135
The ability to track disease without tissue biopsy in patients is a major goal in biology and medicine. Here, we identify and characterize cardiomyocyte-derived extracellular vesicles in circulation (EVs; "cardiovesicles")...
6.
Li Z, Peng X, Zhu X, Spanos M, Wu L
Pharmacology
. 2024 Sep;
110(1):49-61.
PMID: 39250889
Background: Cardiovascular diseases are now the second leading cause of death among cancer patients. Heart injury in patients with terminal cancer can lead to significant deterioration of left ventricular morphology...
7.
Liu S, Spanos M, Wang J, Xiao J
J Cardiovasc Transl Res
. 2024 Jul;
17(5):990-991.
PMID: 39028366
No abstract available.
8.
Meng D, Spanos M, Xiao J
J Cardiovasc Transl Res
. 2024 Jul;
17(6):1466-1467.
PMID: 39009945
No abstract available.
9.
Wang J, Spanos M, Bei Y
J Cardiovasc Transl Res
. 2024 Jul;
17(5):1205-1206.
PMID: 38992315
No abstract available.
10.
Morey A, Ng M, Spanos M, Zhang P, Xu T, Cheung W, et al.
Extracell Vesicle
. 2024 Jun;
3.
PMID: 38872853
Antibodies are critical tools for research into extracellular vesicles (EVs) and other extracellular nanoparticles (ENPs), where they can be used for their identification, characterization, and isolation. However, the lack of...